Pharmaceutical Policy Change and the Safety of New Drugs
Year of publication: |
2013
|
---|---|
Authors: | Olson, Mary K. |
Publisher: |
[S.l.] : SSRN |
Subject: | Arzneimittel | Pharmaceuticals | Pharmaindustrie | Pharmaceutical industry | Arzneimittelmarkt | Pharmaceutical market | Arzneimittelrecht | Pharmaceutical law |
Description of contents: | Abstract [papers.ssrn.com] |
Extent: | 1 Online-Ressource |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | In: Journal of Law and Economics, Vol. 45, No. 2, Part 2, October 2002 Volltext nicht verfügbar |
Classification: | I18 - Government Policy; Regulation; Public Health ; L5 - Regulation and Industrial Policy ; K0 - Law and Economics. General |
Source: | ECONIS - Online Catalogue of the ZBW |
-
The Information Prescription for Drug Regulation
Bernstein, Anita, (2013)
-
Do-it-Yourself Medicine? The Impact of Light Cannabis Liberalization on Prescription Drugs
Carrieri, Vincenzo, (2020)
-
Risky Business : Should the FDA Pay Attention to Drug Prices?
Hyman, David A., (2018)
- More ...
-
Olson, Mary K., (2020)
-
Pharmaceutical expenditure and regulatory policy in the NHS
Olson, Mary K., (1992)
-
Regulatory agency discretion among competing industries : inside the FDA
Olson, Mary K., (1993)
- More ...